These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 12677953)
1. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective]. Dorhout Mees EJ Ned Tijdschr Geneeskd; 2003 Mar; 147(11):521-2; author reply 522. PubMed ID: 12677953 [No Abstract] [Full Text] [Related]
2. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective]. de Boer RA; van Veldhuisen DJ; Gans RO; Gansevoort RT Ned Tijdschr Geneeskd; 2003 Jan; 147(3):96-9. PubMed ID: 12577767 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of hypertension with angiotensin blockers]. Fortschr Med Suppl; 1997; 182():1-12. PubMed ID: 9383918 [No Abstract] [Full Text] [Related]
4. Hypertension: drug therapy options for older patients. Butler RN; August P; Ferdinand KC; Phillips RA; Roccella EJ Geriatrics; 1999 Jul; 54(7):27-8, 33-4, 37. PubMed ID: 10431597 [No Abstract] [Full Text] [Related]
5. NICE removes beta blockers as first line treatment for hypertension. Mayor S BMJ; 2006 Jul; 333(7557):8. PubMed ID: 16809680 [No Abstract] [Full Text] [Related]
6. [Management of hypertension in upheaval?]. Zidek W; Paul M Dtsch Med Wochenschr; 2005 Nov; 130(46):2627. PubMed ID: 16281156 [No Abstract] [Full Text] [Related]
7. Impact of ASCOT on hypertension treatment and guidelines in older adults. Sheridan R; Baldwin N Age Ageing; 2006 May; 35(3):214-7. PubMed ID: 16638764 [No Abstract] [Full Text] [Related]
8. [Blood pressure control in Europe is worse than in the USA]. Minutolo R G Ital Nefrol; 2007; 24(4):284. PubMed ID: 17659496 [No Abstract] [Full Text] [Related]
10. Back to basics: diuretics as first-line agents in the treatment of hypertension. Mandal VJ J Am Geriatr Soc; 2004 Jul; 52(7):1210-1. PubMed ID: 15209664 [No Abstract] [Full Text] [Related]
11. Angiotensin II antagonists in the treatment of hypertension-effective and efficient? Müller-Nordhorn J; Willich SN Herz; 2003 Dec; 28(8):733-7. PubMed ID: 14689108 [TBL] [Abstract][Full Text] [Related]
12. Following evidence-based prescribing guidelines for antihypertensives could save big bucks. Rollins G Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883 [No Abstract] [Full Text] [Related]
13. [Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner?]. Zidek W MMW Fortschr Med; 2004 Jan; 146(1-2):37-8. PubMed ID: 18437867 [No Abstract] [Full Text] [Related]
14. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2? Nicholls MG J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907 [No Abstract] [Full Text] [Related]
15. Selecting antihypertensive medication in patients with essential hypertension in Malaysia. Ong HT; Rozina G Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313 [No Abstract] [Full Text] [Related]
18. High blood pressure: treatment guidelines. How you can silence the "silent killer". Harv Mens Health Watch; 2004 Jan; 8(6):1-4, 6-7. PubMed ID: 14734272 [No Abstract] [Full Text] [Related]
19. [Hypertension therapies compared. Are the new nevertheless better than the old?]. MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780 [No Abstract] [Full Text] [Related]
20. Drug therapy for hypertension in hemodialysis patients. Hörl MP; Tepel M Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]